Cargando…
Convalescent plasma therapy for severe Covid-19 in patients with hematological malignancies
BACKGROUND: Data on convalescent plasma therapy (CPT) in patients of hematological malignancies with severe Covid-19 is scarce. OBJECTIVE: To study 14-day mortality in patients who received CPT. PATIENTS & METHODS: Retrospective multicentre observational study conducted in 4 centres treating hae...
Autores principales: | Jeyaraman, Preethi, Agrawal, Narendra, Bhargava, Rahul, Bansal, Divya, Ahmed, Rayaz, Bhurani, Dinesh, Bansal, Sachin, Rastogi, Neha, Borah, Pronamee, Naithani, Rahul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857080/ https://www.ncbi.nlm.nih.gov/pubmed/33574010 http://dx.doi.org/10.1016/j.transci.2021.103075 |
Ejemplares similares
-
Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: Multicenter Retrospective Analysis
por: Agrawal, Narendra, et al.
Publicado: (2021) -
Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies
por: Borah, Pronamee, et al.
Publicado: (2021) -
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it out
por: Kapoor, Jyotsna, et al.
Publicado: (2021) -
Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in India
por: Mehta, Pallavi, et al.
Publicado: (2021) -
Factors Influencing Adherence to Imatinib in Indian Chronic Myeloid Leukemia Patients: A Cross-Sectional Study
por: Kapoor, Jyotsna, et al.
Publicado: (2015)